Newer Glucose-Lowering Medications and Potential Role in Metabolic Management of PCOS
Anam A, Inzucchi S. Newer Glucose-Lowering Medications and Potential Role in Metabolic Management of PCOS. 2022, 527-553. DOI: 10.1007/978-3-030-92589-5_26.ChaptersPolycystic ovary syndromeType 2 diabetes mellitusDiabetes mellitusSodium-glucose cotransporter 2 inhibitorsGLP-1 receptor agonistsDipeptidyl peptidase-4 inhibitorsWeight lossGLP-1 RAsCV risk factorsGlucose-lowering medicationsCotransporter 2 inhibitorsGlucose lowering medicationsPeptidase-4 inhibitorsHigh-risk populationCategories of medicationsAbnormal carbohydrate metabolismPart of standardCV outcomesLifestyle interventionOvary syndromeMetabolic sequelaeMetabolic abnormalitiesMetabolic managementSGLT2 inhibitorsPatient population